Calidi Biotherapeutics In...

AMEX: CLDI · Real-Time Price · USD
5.28
0.24 (4.76%)
At close: Aug 15, 2025, 3:59 PM
5.24
-0.76%
After-hours: Aug 15, 2025, 07:55 PM EDT

Calidi Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-22.21M -29.22M -25.43M -10.93M
Depreciation & Amortization
1.53M 1.26M 383K 716K
Stock-Based Compensation
2.96M 4.81M 6.14M 1.33M
Other Working Capital
-1.07M -72K 1.95M 1.34M
Other Non-Cash Items
-279K 2.41M 2.12M 19K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-1.7M -6.24M 3.57M 1.1M
Operating Cash Flow
-19.69M -26.98M -13.21M -7.77M
Capital Expenditures
-16K -585K -428K -206K
Cash Acquisitions
n/a 9K n/a n/a
Purchase of Investments
n/a n/a n/a -230M
Sales Maturities Of Investments
n/a n/a 190.01M n/a
Other Investing Acitivies
-16K 98K -190.08M 229.99M
Investing Cash Flow
-16K -478K -494K -215K
Debt Repayment
1.92M 899K 1.38M 348K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
-1.67M n/a n/a n/a
Other Financial Acitivies
9.05M 885K -58K -223.32M
Financial Cash Flow
27.36M 29.04M 12.09M 9.81M
Net Cash Flow
7.64M 1.58M -1.65M 1.82M
Free Cash Flow
-19.71M -27.57M -13.64M -1.29M